Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Improving positive blood culture removal time significantly decreases total processing time.

Salazar E, Divatia M, Cernoch PL, Olsen RJ, Long SW, Land GA, Davis JR, Musser JM.

Arch Pathol Lab Med. 2015 Feb;139(2):199-203. doi: 10.5858/arpa.2013-0681-OA. Epub 2014 May 7.

PMID:
24806519
2.

Intermediate-term graft loss after renal transplantation is associated with both donor-specific antibody and acute rejection.

Devos JM, Gaber AO, Teeter LD, Graviss EA, Patel SJ, Land GA, Moore LW, Knight RJ.

Transplantation. 2014 Mar 15;97(5):534-40. doi: 10.1097/01.TP.0000438196.30790.66.

PMID:
24595116
3.

The presence of anti-HLA donor-specific antibodies in lung allograft recipients does not correlate with C4d immunofluorescence in transbronchial biopsy specimens.

Roberts JA, Barrios R, Cagle PT, Ge Y, Takei H, Haque AK, Burns KM, Land GA, Dilioglou S, Bernard DW.

Arch Pathol Lab Med. 2014 Aug;138(8):1053-8. doi: 10.5858/arpa.2013-0539-OA. Epub 2013 Oct 28.

PMID:
24164556
4.

Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs.

Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Land GA, Peterson LE, Musser JM.

Arch Pathol Lab Med. 2013 Sep;137(9):1247-54. doi: 10.5858/arpa.2012-0651-OA. Epub 2012 Dec 6.

PMID:
23216247
5.

Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation.

DeVos JM, Gaber AO, Knight RJ, Land GA, Suki WN, Gaber LW, Patel SJ.

Kidney Int. 2012 Sep;82(5):598-604. doi: 10.1038/ki.2012.190. Epub 2012 May 23.

6.

Strategy for rapid identification and antibiotic susceptibility testing of gram-negative bacteria directly recovered from positive blood cultures using the Bruker MALDI Biotyper and the BD Phoenix system.

Wimmer JL, Long SW, Cernoch P, Land GA, Davis JR, Musser JM, Olsen RJ.

J Clin Microbiol. 2012 Jul;50(7):2452-4. doi: 10.1128/JCM.00409-12. Epub 2012 Apr 18.

7.

De novo donor specific antibodies and patient outcomes in renal transplantation.

DeVos JM, Patel SJ, Burns KM, Dilioglou S, Gaber LW, Knight RJ, Gaber AO, Land GA.

Clin Transpl. 2011:351-8.

PMID:
22755430
8.

Validation of the MycoAlign system for Mycobacterium spp. identification.

Olsen RJ, Cernoch PA, Austin CM, Graviss EA, Farkas DH, Land GA.

Diagn Microbiol Infect Dis. 2007 Sep;59(1):105-8. Epub 2007 Jun 15.

PMID:
17572036
9.

Immunoglobulin therapy for plasma cell-rich rejection in the renal allograft.

Adrogue HE, Soltero L, Land GA, Ramanathan V, Truong LD, Suki WN.

Transplantation. 2006 Aug 27;82(4):567-9.

PMID:
16926602
10.

Mycobacterial synovitis caused by slow-growing nonchromogenic species: eighteen cases and a review of the literature.

Olsen RJ, Cernoch PL, Land GA.

Arch Pathol Lab Med. 2006 Jun;130(6):783-91.

PMID:
16740028
11.

Impact of left ventricular assist device (LVAD)-mediated humoral sensitization on post-transplant outcomes.

Joyce DL, Southard RE, Torre-Amione G, Noon GP, Land GA, Loebe M.

J Heart Lung Transplant. 2005 Dec;24(12):2054-9. Epub 2005 Sep 15.

PMID:
16364849
12.

Performance assessment of the fecal leukocyte test for inpatients.

Granville LA, Cernoch P, Land GA, Davis JR.

J Clin Microbiol. 2004 Mar;42(3):1254-6.

13.

Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis.

Sun W, Popat U, Hutton G, Zang YC, Krance R, Carrum G, Land GA, Heslop H, Brenner M, Zhang JZ.

Brain. 2004 May;127(Pt 5):996-1008. Epub 2004 Feb 25.

PMID:
14985264
14.

Comparison of panel-reactive antibody levels in Caucasian and African American renal transplant candidates.

Cooper TY, Jordan CL, Willimon CM, Land GA.

Transplantation. 1995 Aug 27;60(4):327-30.

PMID:
7652759
15.

Evaluation of the Baxter-MicroScan 4-hour enzyme-based yeast identification system.

Land GA, Salkin IF, el-Zaatari M, McGinnis MR, Hashem G.

J Clin Microbiol. 1991 Apr;29(4):718-22.

16.

Evaluation of the updated Vitek yeast identification data base.

el-Zaatari M, Pasarell L, McGinnis MR, Buckner J, Land GA, Salkin IF.

J Clin Microbiol. 1990 Sep;28(9):1938-41.

17.

Uncommon yeastlike zoopathogens and commercial systems for their identification.

Land GA, Salkin IF.

Mycopathologia. 1987 Sep;99(3):155-71. Review.

PMID:
3309664
18.

Evaluation of YeastIdent and Uni-Yeast-Tek yeast identification systems.

Salkin IF, Land GA, Hurd NJ, Goldson PR, McGinnis MR.

J Clin Microbiol. 1987 Apr;25(4):624-7.

19.

Taxonomic and nomenclatural evaluation of the genera Candida and Torulopsis.

McGinnis MR, Ajello L, Beneke ES, Drouhet E, Goodman NL, Halde CJ, Haley LD, Kane J, Land GA, Padhye AA, et al.

J Clin Microbiol. 1984 Oct;20(4):813-4.

20.

Evaluation of the exoantigen test for identification of Histoplasma species and Coccidioides immitis cultures.

DiSalvo AF, Sekhon AS, Land GA, Fleming WH.

J Clin Microbiol. 1980 Mar;11(3):238-41.

21.
23.

Evaluation of the new API 20C strip for yeast identification against a conventional method.

Land GA, Harrison BA, Hulme KL, Cooper BH, Byrd JC.

J Clin Microbiol. 1979 Sep;10(3):357-64.

24.

Improved blood culture technique based on centrifugation: clinical evaluation.

Dorn GL, Land GA, Wilson GE.

J Clin Microbiol. 1979 Mar;9(3):391-6.

25.

Isolation and rapid identification of yeasts from compromised hosts.

Land GA, Dorn GL, Fleming WH 3rd, Beadles TA, Foxworth JH.

Mycopathologia. 1978 Dec 18;65(1-3):123-31.

PMID:
370600
26.

Immunodiagnosis of histoplasmosis in a compromised host.

Land GA, Foxworth JH, Smith KE.

J Clin Microbiol. 1978 Nov;8(5):558-65.

27.

Rapid urea broth test for yeasts.

Roberts GD, Horstmeier CD, Land GA, Foxworth JH.

J Clin Microbiol. 1978 Jun;7(6):584-8.

28.

Rapid method for determining nitrate utilization by yeasts.

Hopkins JM, Land GA.

J Clin Microbiol. 1977 Apr;5(4):497-500.

29.
31.

Improved auxanographic method for yeast assimilations: a comparison with other approaches.

Land GA, Vinton EC, Adcock GB, Hopkins JM.

J Clin Microbiol. 1975 Sep;2(3):206-17.

32.
33.

Supplemental Content

Support Center